07.02.2025 • News

BP Wants to Sell German Refinery in Gelsenkirchen

Oil giant BP announced plans to sell its refinery in Gelsenkirchen, Germany, operating under the name Ruhr Oel. The assets to be divested include the refinery in Gelsenkirchen and DHC Solvent Chemie in Mülheim an der Ruhr, Germany.

According to BP, the process of finding a suitable buyer has already begun and the company is aiming for purchase agreements in 2025. However, the timeline for finalizing the sale and transferring the assets to a new owner will be subject to regulatory and government approvals. During the sales process, the refinery will continue to operate as usual, BP stated.

Emma Delaney, BP’s executive vice president, customers & products, commented: “BP needs to continually manage its global portfolio as we position to grow as a simpler, more focused, higher-value company. After a thorough review, we have concluded that a new owner would be better suited for the site to take it forward.”

BP said that it has carried out numerous projects to modernize the infrastructure of the refinery in Gelsenkirchen in recent years, for example, the renewal of the electricity network and the establishment of an independent steam supply.

Today, the refinery can process crude oils, produce high-quality fuels and also has the potential to manufacture biofuels and process recycled plastics.

Patrick Wendeler, CEO of BP Europa, said: “With significant investments, we have been able to substantially modernize our site in recent years. Due to its current production capabilities and its location – in the heart of Europe and particularly within the chemical cluster of North Rhine-Westphalia – it offers significant potential to a new owner supported by a highly qualified team.”

BP’s refinery at Gelsenkirchen, Germany. │ © BP
BP’s refinery at Gelsenkirchen, Germany. │ © BP

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read